Scheme 1From: Activation of dopamine receptor D1 promotes osteogenic differentiation and reduces glucocorticoid-induced bone loss by upregulating the ERK1/2 signaling pathwayDexamethasone inhibites osteogenic differentiation and induces bone loss by inhibiting the activation of dopamine receptor D1 via downregulating the ERK1/2 signaling pathwayBack to article page